F. Tosi

发表

Insulin-Mediated Substrate Utilization in Women with the Different Phenotypes of PCOS: Role of Androgens.

J. Kaufman, E. Bonora, T. Fiers, 2021, The Journal of clinical endocrinology and metabolism.

The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.

M. Muggeo, F. Tosi, P. Moghetti, 1996, The Journal of clinical endocrinology and metabolism.

Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone

E. Bonora, G. Zoppini, M. Muggeo, 1992, Journal of endocrinological investigation.

Assessment of β‐cell function during the oral glucose tolerance test by a minimal model of insulin secretion

F Tosi, L. Groop, E. Bonora, 2001, European journal of clinical investigation.

Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized, double-blind, comparative study.

M. Muggeo, F. Tosi, P. Moghetti, 2003, Metabolism: clinical and experimental.

Insulin resistance and PCOS: chicken or egg?

F. Tosi, P. Moghetti, 2020, Journal of Endocrinological Investigation.

Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women

F. Tosi, P. Moghetti, R. Castello, 1998, Clinical endocrinology.

Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.

E. Bonora, F. Tosi, P. Moghetti, 2012, The Journal of clinical endocrinology and metabolism.

Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.

A. Tosti, M. Muggeo, F. Tosi, 2000, The Journal of clinical endocrinology and metabolism.

Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study

E. Bonora, M. Muggeo, G. Targher, 1997, European journal of clinical investigation.

Serum Androgens are Independent Predictors of Insulin Clearance But Not of Insulin Secretion in Women With Pcos.

J. Kaufman, E. Bonora, T. Fiers, 2020, The Journal of clinical endocrinology and metabolism.

Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes

E. Bonora, F. Tosi, P. Moghetti, 2017, Human reproduction.

Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome.

J. Kaufman, E. Bonora, T. Fiers, 2016, The Journal of clinical endocrinology and metabolism.

Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome.

J. Kaufman, E. Bonora, F. Tosi, 2015, The Journal of clinical endocrinology and metabolism.

Serum testosterone predicts cardiorespiratory fitness impairment in normal‐weight women with polycystic ovary syndrome

J. Kaufman, E. Bonora, F. Schena, 2015, Clinical endocrinology.

Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome.

J. Kaufman, E. Bonora, T. Fiers, 2014, European journal of endocrinology.

1 1 PLASMA LEVELS OF PENTRAXIN-3 , AN INFLAMMATORY PROTEIN INVOLVED IN 1 FERTILITY , ARE REDUCED IN WOMEN WITH POLYCYSTIC OVARY SYNDROME 2 3 1

J. Kaufman, E. Bonora, T. Fiers, 2013 .

Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women.

E. Bonora, V. Toscano, M. Muggeo, 2011, European journal of endocrinology.

Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjects

E. Bonora, G. Zoppini, M. Muggeo, 1990, Acta diabetologia latina.

Plasma concentrations of growth hormone during hyperglycemic clamp with or without somatostatin infusion in obese subjects.

E. Bonora, M. Muggeo, F. Tosi, 1990, The Journal of clinical endocrinology and metabolism.

Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism.

E. Bonora, M. Muggeo, F. Tosi, 1996, Metabolism: clinical and experimental.

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

M. Muggeo, F. Tosi, P. Moghetti, 2000, The Journal of clinical endocrinology and metabolism.

Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome.

J. L. San Millán, G. Villuendas, H. Escobar-Morreale, 2003, Fertility and sterility.

B cell secretion and insulin sensitivity in hypertensive and normotensive obese subjects.

E. Bonora, M. Muggeo, F. Tosi, 1990, International journal of obesity.

Polycystic ovary syndrome as a diabetes risk factor

F. Tosi, P. Moghetti, 2013, Expert review of endocrinology & metabolism.

Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome

G. Zoppini, M. Muggeo, G. Targher, 2009, Journal of endocrinological investigation.

Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.

M. Muggeo, F. Tosi, P. Moghetti, 2000, The Journal of clinical endocrinology and metabolism.

Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.

V. Toscano, M. Muggeo, F. Tosi, 1996, The Journal of clinical endocrinology and metabolism.

Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads.

M. Muggeo, F. Tosi, P. Moghetti, 1995, The Journal of clinical endocrinology and metabolism.

SPIRONOLACTONE, BUT NOT FLUTAMIDE, ADMINISTRATION PREVENTS BONE LOSS IN HYPERANDROGENIC WOMEN TREATED WITH GONADOTROPIN-RELEASING HORMONE AGONIST

M. Muggeo, F. Tosi, P. Moghetti, 1999 .

Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist.

M. Muggeo, F. Tosi, P. Moghetti, 1999, Journal of Clinical Endocrinology and Metabolism.

Glucose counterregulatory response to acute hypoglycemia in hyperthyroid human subjects.

M. Muggeo, F. Tosi, P. Moghetti, 1994, The Journal of clinical endocrinology and metabolism.

M. Muggeo, F. Tosi, P. Moghetti, 2000, The Journal of clinical endocrinology and metabolism.

Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.

J. Kaufman, C. Signori, E. Bonora, 2013, The Journal of clinical endocrinology and metabolism.

Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study.

E. Bonora, M. Muggeo, G. Targher, 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism.

J. Kaufman, C. Signori, E. Bonora, 2013, The Journal of clinical endocrinology and metabolism.

Clustering of cardiovascular risk factors associated with the insulin resistance syndrome: assessment by principal component analysis in young hyperandrogenic women.

G. Zoppini, M. Muggeo, F. Tosi, 2006, Diabetes care.

Physical Activity Patterns in Normal-Weight and Overweight/Obese Pregnant Women

E. Bonora, F. Tosi, P. Moghetti, 2016, PloS one.

Authors’ Response: Spironolactone But Not Flutamide Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist

M. Muggeo, F. Tosi, P. Moghetti, 1999 .

Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism.

D. Armanini, M. Muggeo, F. Tosi, 1994, The Journal of clinical endocrinology and metabolism.

Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.

G. Zoppini, M. Muggeo, C. Maffeis, 2009, European journal of endocrinology.

Acute Effect of Insulin on Autonomic Regulation of the Cardiovascular System: A Study by Heart Rate Spectral Analysis

M. Muggeo, F. Bellavere, F. Tosi, 1996, Diabetic medicine : a journal of the British Diabetic Association.

Trimester-specific reference intervals for thyroid function parameters in pregnant Caucasian women using Roche platforms: a prospective study.

F. Tosi, P. Moghetti, R. Dorizzi, 2023, Journal of endocrinological investigation.

Clinical Value Of Serum Levels Of 11-Oxygenated Metabolites Of Testosterone In Women With Polycystic Ovary Syndrome.

J. Kaufman, E. Bonora, T. Fiers, 2021, The Journal of clinical endocrinology and metabolism.

Mononuclear Leukocytes from Obese Patients with Type II Diabetes have Reduced Activity of Hexokinase, 6-Phosphofructokinase and Glucose-6-Phosphate Dehydrogenase

E. Bonora, G. Zoppini, M. Muggeo, 1993, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS.

T. Fiers, F. Tosi, P. Moghetti, 2023, Journal of Endocrinological Investigation.

Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up.

M. Muggeo, F. Tosi, P. Moghetti, 1996, Fertility and sterility.

Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism.

J. Kaufman, C. Signori, E. Bonora, 2013, The Journal of clinical endocrinology and metabolism.

Serum testosterone predicts cardiorespiratory fitness impairment in normal‐weight women with polycystic ovary syndrome

J. Kaufman, E. Bonora, F. Schena, 2015, Clinical endocrinology.